Delivery Order SPE2DB24D1205-SPE2DB25FCZKK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,957.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,151.46. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order valued at $1,880.82 to AmerisourceBergen Drug Corp for the supply of Adderall XR 15 mg capsules (100 count) under a firm fixed-price contract type. This non-set-aside award was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,648.34. This competitively awarded, firm fixed-price delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, indicating open...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $3,846.89. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,431,067 units of Adderall XR 10 mg capsules. The $3,503.80 delivery order is part of a larger contract between Amerisourcebergen Drug Corp and DLA to provide pharmaceuticals and medical supplies to support military treatment programs and facilities. Amerisourcebergen Drug Corp, as a prime contractor, has extensive experience...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,097.62 for Adderall XR 5 mg capsules (100-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,384.37 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This firm fixed-price contract, with an ultimate completion date of August 1, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis and will be performed at the vendor's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,057.62. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's broader pharmaceutical supply arrangement with the agency. The place of performance is the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $2.66K. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The order is scheduled for completion by July 30, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZKKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 15 mg capsules (100-count units) under a firm fixed price contract type. This non-set-aside competitive award carries a ceiling value of $1,095.80 and was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution center. This delivery order represents a task issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical federal medical vendor, particularly for military and veteran healthcare systems. The company's IDC covers a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, enabling the delivery of medications, vaccines, and specialized medical commodities to support military healthcare programs globally. This particular delivery order for controlled-release amphetamine medication reflects the company's ongoing role in supplying neurological and behavioral health treatments to Defense Health Agency customers and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/11/25 |